Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Denys-Drash Syndrome

ClinicalTrials.gov lists 4 trials for Denys-Drash Syndrome or a narrower condition beneath it.

MeSH D030321 Neoplasms Neoplasm C04 C12 C16 C19 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 3 Publications Publications 4 Prevalence Prevalence 6 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 3 Publications Publications 4 Prevalence Prevalence 6 Rare-disease identity Rare-disease identity 2

Rows recorded per section

3 sections measured, none recorded · 1 not measured yet · 1 not computed

4 of the 4 trials are tagged with Denys-Drash Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Denys-Drash Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Denys-Drash Syndrome trials start? (3)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2026 (partial year) 1
2010 2
2009 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Denys-Drash Syndrome trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Observational 4

How many Denys-Drash Syndrome trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 2
Completed 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Denys-Drash Syndrome? (4)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (6)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Denys-Drash syndrome Point prevalence Unknown Worldwide Not stated Exact
Denys-Drash syndrome Point prevalence Unknown Worldwide Not stated Unspecified
Denys-Drash syndrome Cases families Worldwide Not stated Exact
Denys-Drash syndrome Cases families Worldwide Not stated Exact
Denys-Drash syndrome Cases families Worldwide Not stated Unspecified

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Denys-Drash syndrome 220 Exact Orphanet Rare Disease Ontology (ORDO)
Denys-Drash syndrome 220 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages